Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:clindamycin
benzoyl peroxide |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
D10AF51
|
| gptkbp:contraindication |
hypersensitivity to clindamycin
hypersensitivity to benzoyl peroxide |
| gptkbp:form |
gel
|
| gptkbp:frequency |
once daily
|
| https://www.w3.org/2000/01/rdf-schema#label |
Acanya
|
| gptkbp:manufacturer |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:powers |
clindamycin phosphate 1% / benzoyl peroxide 2.5%
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
peeling
skin irritation redness dryness |
| gptkbp:usedFor |
acne vulgaris
|
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|